COMPASS FINANCIAL MANAGEMENT LLC’s Olema Pharmaceuticals OLMA Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.62K	Buy	+308	New	+$4.13K	﹤0.01%	1246

Other funds holding OLMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's OLMA Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 308 shares worth $3.62K. The stake represents ﹤0.01% of the portfolio and ranks #1246 among its holdings.

90 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 308 shares of Olema Pharmaceuticals worth $3.62K as of Q2 2026.
Olema Pharmaceuticals was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Olema Pharmaceuticals made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1246 holding.
90 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.